Influences of preoperative metformin on immunological factors in early breast cancer.

Cancer Chemotherapy and Pharmacology
Takahiro TsukiokiShinichi Toyooka

Abstract

Metformin has been suggested to possibly reduce cancer risk. However, the mechanism underlying the positive effects of metformin on cancer treatment remains unclear. We conducted a prospective study to evaluate the effects of preoperative metformin in patients with early breast cancer. We evaluated the effects on immunological factors (TILs, CD4 + , CD8 + , PD-L1, IFNγ and IL-2) by comparing core needle biopsies (CNB) obtained before metformin treatment with surgical specimens. Seventeen patients were enrolled in this prospective study from January to December 2016. We also analyzed 59 patients undergoing surgery during the same period to reveal the correlation of immune factors between CNB and surgical specimen. There was a moderate correlation between CNB and surgical specimens on TILs and CD8 + lymphocyte. (TILs Rs = 0.63, CD4 + Rs = 0.224, CD8 + Rs = 0.42) In the metformin group, TILs increases were confirmed in five (29%) patients, while a decrease was confirmed in two (12%). The expressions of CD4 + and CD8 + by TILs were increased in 41% and 18% of surgical specimens, respectively. However, TILs number (p = 0.0554), CD4+ (p = 0.0613) and CD8 + (p = 0.0646) expressions did not significantly increased. Furthermore, IFNγ ex...Continue Reading

References

Jun 1, 1997·Immunology Today·S Romagnani
Aug 30, 2000·Nature·C M PerouD Botstein
Jun 29, 2007·Journal of the National Cancer Institute·William J M HrusheskyRomano Demicheli
Jul 2, 2008·Breast Cancer Research and Treatment·Robin L JonesMitchell Dowsett
Nov 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe VialeUNKNOWN Breast International Group Trial 1-98
Feb 21, 2009·The New England Journal of Medicine·Christos Sotiriou, Lajos Pusztai
Apr 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José BaselgaHope S Rugo
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten DenkertGunter von Minckwitz
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sahar M A MahmoudAndrew R Green
Jul 9, 2011·Nature Immunology·E John Wherry
Jun 20, 2013·The Journal of Clinical Investigation·Chunyan Gu-TrantienKaren Willard-Gallo
Sep 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R SalgadoUNKNOWN International TILs Working Group 2014
Dec 24, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten DenkertSibylle Loibl
Jan 28, 2015·Proceedings of the National Academy of Sciences of the United States of America·Shingo EikawaHeiichiro Udono
Jul 2, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Carsten DenkertRoberto Salgado
Dec 13, 2016·Cancer Immunology Research·Nicole E ScharpingGreg M Delgoffe
Oct 23, 2018·The New England Journal of Medicine·Peter SchmidUNKNOWN IMpassion130 Trial Investigators

❮ Previous
Next ❯

Citations

Oct 7, 2021·Journal of Cell Communication and Signaling·Zihong WuMasoud Najafi

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
biopsy
biopsies

Clinical Trials Mentioned

NCT01101438
NCT02488564

Related Concepts

Related Feeds

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Shingo EikawaHeiichiro Udono
British Journal of Cancer
Marie Christine Wulff WestergaardInge Marie Svane
Nature Immunology
Zoltan Fehervari
© 2022 Meta ULC. All rights reserved